Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

Jamie Baumgartner, Jonathan Grinstein, and John Wilkerson go behind the headlines to discuss the implications of personalized gene-editing therapies, more HHS policy and funding updates, and the latest tariff-related investments. 

Behind the Headlines, Episode 17: Bespoke CRISPR Therapy, Executive Order Fallout, and More

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Articles

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only multiple myeloma, but other specific cancers as well.

CellCentric Completes $120 Million Series C Funding Round for Multiple Myeloma Treatment Inobrodib

ACG partnered with Art of You to launch the world-first Personalised Capsule Machine, enabling on-demand, customized supplement capsules based on individual health data.

Personalised Capsule Machine Unveiled by ACG

The LP.8.1 variant of the SARS-CoV-2 virus differs from the JN.1 family that previous vaccines had been designed to target, and has surpassed JN.1 as the variant circulating most widely worldwide.

EMA Recommends Update to COVID-19 Vaccines for 2025-26 Campaign

Researchers say they have discovered the first drug mechanism that binds to the pyrin domain to block NLRP3 and prevent a series of reactions resulting in inflammation.

UC Irvine Lab Studies NLRP3 Inflammasome for Inflammatory Disease Treatment Potential

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

Merck KGaA Becomes Strategic Partner in Peregrine Ventures’ Incentive Incubator

Six winners and two honorable mentions were revealed at ISPE’s Europe Annual Conference in London.

ISPE Announces Six 2025 FOYA Category Winners

According to the White House, the order builds on actions taken in the president’s first term to reduce price disparities domestically.

Trump Issues Executive Order Aimed at Reducing Prescription Drug Prices for US Patients

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

Genentech and Roche Expand US Footprint with New North Carolina Manufacturing Facility

The company said the investment is in response not only to customer demand and a belief in the value of US-based innovation, but also because of the trend toward US onshoring brought about by new tariff policies.

News